Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In the large REducing With MetfOrmin Vascular Adverse Lesions (REMOVAL) trial, however, metformin did not reduce the long-term insulin needs or improve glycaemic control in people with long-standing type 1 diabetes and multiple cardiovascular risk factors [76]
10.1038/nchembio.1416 31 DollS.FreitasF
While pharmaceutical interventions for enhancing GLP-1 activity exist, exploring natural sources offers a holistic and more sustainable approach to metabolic health
Maslak P, Espiritu E, Godfrey L, Andreeff M
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
